Business Continuity and Risk Mitigation in the Pharmaceutical Industry: Strengthening Supply Chains for Pandemic Preparedness

The COVID-19 pandemic exposed vulnerabilities in pharmaceutical supply chains, underscoring the importance of robust business continuity and risk management to ensure the steady supply of essential medical products. The article discusses challenges such as raw material sourcing, production constraints, regulatory hurdles, and distribution delays. It suggests improvements like diversifying supplier networks, using AI and blockchain for real-time tracking, and adopting stockpiling and flexible manufacturing strategies. Public-private partnerships and regulatory bodies are deemed crucial for enhancing industry readiness for future pandemics.